BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a large growth in short interest in January. As of January 31st, there was short interest totalling 3,900 shares, a growth of 225.0% from the January 15th total of 1,200 shares. Based on an average trading volume of 14,800 shares, the short-interest ratio is currently 0.3 days.

BioSyent Price Performance

Shares of OTCMKTS BIOYF traded up $0.01 during midday trading on Thursday, reaching $7.82. 230 shares of the company traded hands, compared to its average volume of 4,919. The stock has a 50-day moving average price of $7.84 and a 200 day moving average price of $7.85. BioSyent has a 52 week low of $5.93 and a 52 week high of $8.90.

BioSyent Cuts Dividend

The business also recently declared a dividend, which was paid on Monday, December 16th. Shareholders of record on Monday, December 2nd were given a dividend of $0.0322 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a dividend yield of 1.6%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.